Lastly, we investigated those biomarker changes leading to cognitive decline, bringing together both measures of soluble p-tau and tau aggregates accumulation as they follow more closely the apparition of symptoms than Aβ pathology30,31. The gene discussed is MAPT; the disease is Mental deterioration.